Litigation Details for Novartis Pharmaceuticals Corporation v. Handa Neuroscience, LLC (N.D. Cal. 2021)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Handa Neuroscience, LLC (N.D. Cal. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-05-06 |
| Court | District Court, N.D. California | Date Terminated | 2022-03-18 |
| Cause | 35:145 Patent Infringement | Assigned To | |
| Jury Demand | None | Referred To | |
| Patents | 10,543,179; 9,187,405 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Handa Neuroscience, LLC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Novartis Pharmaceuticals Corporation v. Handa Neuroscience, LLC (N.D. Cal. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-05-06 | 3 | Patent/Trademark Report | the filing of an action regarding Patent Nos. 9,187,405 and 10,543,179 (cc: form mailed to register). (…May 2021 18 March 2022 5:21-cv-03397 Patent - Abbreviated New Drug Applications (ANDA) | External link to document |
| 2021-05-06 | 7 | Complaint | .S. Patent Nos. 9,187,405 (“the ’405 patent”) and 10,543,179 (“the ’179 10 patent”). …. This is an action for patent infringement arising under the patent laws of the United …with respect to the ’405 and ’179 patents asserting that both patents are invalid, 10 unenforceable…listed on U.S. Patent Nos. 8 9,925,138, 10,555,902, and 10,925,829 (“Liu Patents”). … THE PATENTS-IN-SUIT 23 35. On November 17, 2015, the U.S. Patent and Trademark | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
